Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
NDTV
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield, the company said adding, it is stable at 2-8 C.
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
The company claimed that GEMCOVAC-OM is the first booster COVID-19 vaccine developed in India against the Omicron variant.
In a virtual press conference, Gennova Biopharmaceuticals Ltd CEO Dr Sanjay Singh said the booster vaccine demonstrated robust immune responses in about 3,000 subjects in the clinical trials conducted at 20 centres across 13 cities in India.
It was proven safe and well tolerated with no adverse events while the efficacy was also superior, he added.
